TY - JOUR
T1 - Antagonistic Effect of a Salivary Proline-Rich Peptide on the Cytosolic Ca2+ Mobilization Induced by Progesterone in Oral Squamous Cancer Cells.
AU - Palmerini, Carlo Alberto
AU - Mazzoni, Manuela
AU - Radicioni, Giorgia
AU - Marzano, Valeria
AU - Granieri, Letizia
AU - Iavarone, Federica
AU - Longhi, R
AU - Messana, Irene
AU - Cabras, Tiziana
AU - Sanna, Maria Teresa
AU - Castagnola, Massimo
AU - Vitali, Alberto
PY - 2016
Y1 - 2016
N2 - A salivary proline-rich peptide of 1932 Da showed a dose-dependent antagonistic effect on the cytosolic Ca2+ mobilization induced by progesterone in a tongue squamous carcinoma cell line. Structure-activity studies showed that the activity of the peptide resides in the C-terminal region characterized by a proline stretch flanked by basic residues. Furthermore, lack of activity of the retro-inverso peptide analogue suggested the involvement of stereospecific recognition. Mass spectrometry-based shotgun analysis, combined with Western blotting tests and biochemical data obtained with the Progesterone Receptor Membrane Component 1 (PGRMC1) inhibitor AG205, showed strong evidence that p1932 performs its modulatory action through an interaction with the progesterone receptor PGRMC1, which is predominantly expressed in this cell line and, clearly, plays a role in progesterone induced Ca2+ response. Thus, our results point to p1932 as a modulator of the transduction signal pathway mediated by this protein and, given a well-established involvement of PGRMC1 in tumorigenesis, highlight a possible therapeutic potential of p1932 for the treatment of oral cancer.
AB - A salivary proline-rich peptide of 1932 Da showed a dose-dependent antagonistic effect on the cytosolic Ca2+ mobilization induced by progesterone in a tongue squamous carcinoma cell line. Structure-activity studies showed that the activity of the peptide resides in the C-terminal region characterized by a proline stretch flanked by basic residues. Furthermore, lack of activity of the retro-inverso peptide analogue suggested the involvement of stereospecific recognition. Mass spectrometry-based shotgun analysis, combined with Western blotting tests and biochemical data obtained with the Progesterone Receptor Membrane Component 1 (PGRMC1) inhibitor AG205, showed strong evidence that p1932 performs its modulatory action through an interaction with the progesterone receptor PGRMC1, which is predominantly expressed in this cell line and, clearly, plays a role in progesterone induced Ca2+ response. Thus, our results point to p1932 as a modulator of the transduction signal pathway mediated by this protein and, given a well-established involvement of PGRMC1 in tumorigenesis, highlight a possible therapeutic potential of p1932 for the treatment of oral cancer.
KW - Proline-Rich
KW - Salivary
KW - Proline-Rich
KW - Salivary
UR - https://publicatt.unicatt.it/handle/10807/96012
UR - https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84958206378&origin=inward
UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84958206378&origin=inward
U2 - 10.1371/journal.pone.0147925
DO - 10.1371/journal.pone.0147925
M3 - Article
SN - 1932-6203
VL - 11
SP - e0147925.-e0147925.
JO - PLoS One
JF - PLoS One
IS - 1
ER -